A new weekly injection may soon transform how millions manage Parkinson’s disease. For over 8.5 million people living with this condition worldwide, daily treatment has meant taking levodopa and ...

For the past 7 years, pharmaceuticals that work as glucagon-like peptide 1 (GLP-1) receptor agonists have dominated the weight-loss and diabetes markets. These drugs, currently so ...

G whiz! The latest experimental GLP-1 from Eli Lilly isn’t just a diabetes drug — it also facilitates weight loss. Known as ...

The U.S. Food and Drug Administration’s approval of Eli Lilly’s once-daily pill orforglipron as a weight loss and obesity ...

An anti-inflammation injectable drug called dupilumab can reduce mucus buildup and improve breathing among asthma patients, a new clinical trial says. Photo by Adobe Stock/HealthDay News An ...

The Eisai- and Biogen-partnered Alzheimer’s disease drug Leqembi has been available to date as an intravenous infusion that takes about an hour. Patients will soon have the option to choose an ...

Individuals at risk for sexually acquired HIV have a new injectable option for preexposure prophylaxis (PrEP) with the US Food and Drug Administration’s (FDA’s) approval of lenacapavir, according to a ...

LONDON — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus’ transmission. Subscribe to ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE - This colorized electron microscope image provided by the U.S. National Institutes of Health shows a human T cell, in blue, ...

CLEVELAND, Ohio — A recent clinical trial led by the University of Cincinnati looked at whether people living with HIV were more likely to take a monthly injection or a daily pill as treatment. The ...